EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses... Show more
The 10-day RSI Oscillator for ESLOY moved out of overbought territory on August 25, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 instances where the indicator moved out of the overbought zone. In of the 36 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Moving Average Convergence Divergence Histogram (MACD) for ESLOY turned negative on August 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESLOY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ESLOY broke above its upper Bollinger Band on August 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Momentum Indicator moved above the 0 level on August 13, 2025. You may want to consider a long position or call options on ESLOY as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ESLOY advanced for three days, in of 337 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 278 cases where ESLOY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.223) is normal, around the industry mean (10.755). P/E Ratio (51.331) is within average values for comparable stocks, (57.297). ESLOY's Projected Growth (PEG Ratio) (2.899) is slightly higher than the industry average of (1.848). Dividend Yield (0.015) settles around the average of (0.016) among similar stocks. P/S Ratio (4.480) is also within normal values, averaging (37.913).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ESLOY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.
Ticker / NAME | Correlation To ESLOY | 1D Price Change % | ||
---|---|---|---|---|
ESLOY | 100% | -0.90% | ||
ESLOF - ESLOY | 58% Loosely correlated | +0.07% | ||
QGEN - ESLOY | 43% Loosely correlated | -3.85% | ||
ALC - ESLOY | 38% Loosely correlated | -2.36% | ||
SMMNY - ESLOY | 38% Loosely correlated | +0.84% | ||
CRL - ESLOY | 35% Loosely correlated | +0.26% | ||
More |
Ticker / NAME | Correlation To ESLOY | 1D Price Change % |
---|---|---|
ESLOY | 100% | -0.90% |
Pharmaceuticals category (390 stocks) | 37% Loosely correlated | +0.31% |
Pharmaceuticals: Other category (105 stocks) | 32% Poorly correlated | -0.58% |